ICOPE program for older adults with myeloma
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This trial tests whether a program called ICOPE MONITOR, which uses a smartphone app or chatbot, can help older adults with multiple myeloma stay healthier and manage their care. It may be a good fit if you are 70+ and starting your first or second treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years or older
- You have multiple myeloma and are starting or continuing your first or second line of treatment
- You are able to use a smartphone, tablet, or computer (or have a caregiver who can)
- You understand, read, and speak French (or your caregiver does)
- You are not in palliative care, and you are willing to follow the ICOPE MONITOR program
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a personalized care plan for people 60 and older who have finished Step 2 of the ICOPE program. It aims to see if this plan helps improve your health and independence.
This study tests whether remote monitoring and health coaching can improve quality of life in older adults with multiple myeloma who are experiencing fatigue. You'll use a tablet or smartphone to track symptoms and get support from a coach.
This trial tests a personalized treatment approach for people aged 65 and older with newly diagnosed multiple myeloma. The goal is to tailor therapy based on each patient's level of frailty, which could help improve outcomes and reduce side effects.
This study tests a volunteer-led program to improve muscle health in older adults with sarcopenia. It uses a mobile app to guide exercise and nutrition, and aims to see if this approach helps people regain strength.
This study uses your self-reported symptoms (PRO) and wearable/device data to help improve care for people with relapsed multiple myeloma who are starting new treatment. It may help by providing insights about how you’re doing during therapy—without changing your cancer treatment in a study-specific way.
This study helps doctors identify older adults at risk of losing physical strength and independence, and tests ways to prevent that decline. You'll be screened for your overall fitness and given guidance to stay healthy as you age.
Hear when a new Frailty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.